Discover Novartis AG's innovative patent for a solid phase pharmaceutical composition, enhancing stability and bioavailability with unique excipients and precise formulation.
*In instances where patient numbers were not reported they were calculated from the percentages, and in instances where percentages were not reported, percentages were calculated from patient numbers.